

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | uronic acid metabolic process (GO:0006063) | 9.70660212 |
| 2 | glucuronate metabolic process (GO:0019585) | 9.70660212 |
| 3 | cellular glucuronidation (GO:0052695) | 8.77077391 |
| 4 | phosphate ion transmembrane transport (GO:0035435) | 7.81258871 |
| 5 | one-carbon compound transport (GO:0019755) | 7.43810770 |
| 6 | urate metabolic process (GO:0046415) | 6.76238632 |
| 7 | epoxygenase P450 pathway (GO:0019373) | 6.59529993 |
| 8 | polyol transport (GO:0015791) | 6.58729242 |
| 9 | phosphate ion transport (GO:0006817) | 6.54281771 |
| 10 | drug transmembrane transport (GO:0006855) | 6.29121758 |
| 11 | angiotensin maturation (GO:0002003) | 5.97034639 |
| 12 | diterpenoid biosynthetic process (GO:0016102) | 5.69049297 |
| 13 | benzene-containing compound metabolic process (GO:0042537) | 5.65078503 |
| 14 | glutathione derivative biosynthetic process (GO:1901687) | 5.64882943 |
| 15 | glutathione derivative metabolic process (GO:1901685) | 5.64882943 |
| 16 | regulation of skeletal muscle contraction (GO:0014819) | 5.55323013 |
| 17 | interferon-gamma secretion (GO:0072643) | 5.54842065 |
| 18 | toxin transport (GO:1901998) | 5.52587784 |
| 19 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 5.40965372 |
| 20 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 5.40965372 |
| 21 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.17831723 |
| 22 | flavonoid metabolic process (GO:0009812) | 5.09334582 |
| 23 | drug transport (GO:0015893) | 5.08842543 |
| 24 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.99582100 |
| 25 | phenylpropanoid metabolic process (GO:0009698) | 4.97224244 |
| 26 | omega-hydroxylase P450 pathway (GO:0097267) | 4.92456051 |
| 27 | Notch signaling involved in heart development (GO:0061314) | 4.81634216 |
| 28 | type B pancreatic cell proliferation (GO:0044342) | 4.80237552 |
| 29 | renal absorption (GO:0070293) | 4.73555882 |
| 30 | cell differentiation involved in metanephros development (GO:0072202) | 4.68003382 |
| 31 | protein prenylation (GO:0018342) | 4.67076222 |
| 32 | prenylation (GO:0097354) | 4.67076222 |
| 33 | peptide catabolic process (GO:0043171) | 4.65174492 |
| 34 | L-ascorbic acid metabolic process (GO:0019852) | 4.62579397 |
| 35 | facial nerve structural organization (GO:0021612) | 4.56132409 |
| 36 | glutathione metabolic process (GO:0006749) | 4.47214408 |
| 37 | regulation of cardioblast proliferation (GO:0003264) | 4.44303921 |
| 38 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 4.44303921 |
| 39 | response to muramyl dipeptide (GO:0032495) | 4.40179464 |
| 40 | NADH metabolic process (GO:0006734) | 4.37287620 |
| 41 | intestinal absorption (GO:0050892) | 4.33400838 |
| 42 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.30077947 |
| 43 | glutathione biosynthetic process (GO:0006750) | 4.25821628 |
| 44 | hepatocyte differentiation (GO:0070365) | 4.22385423 |
| 45 | desmosome organization (GO:0002934) | 4.21155324 |
| 46 | sphingomyelin metabolic process (GO:0006684) | 4.17327138 |
| 47 | nonribosomal peptide biosynthetic process (GO:0019184) | 4.12935758 |
| 48 | regulation of chemokine secretion (GO:0090196) | 4.12432674 |
| 49 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.09950848 |
| 50 | auditory receptor cell differentiation (GO:0042491) | 4.09421885 |
| 51 | sulfation (GO:0051923) | 4.03415160 |
| 52 | vitamin D metabolic process (GO:0042359) | 3.91941817 |
| 53 | pharyngeal system development (GO:0060037) | 3.91180991 |
| 54 | regulation of guanylate cyclase activity (GO:0031282) | 3.91004349 |
| 55 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 3.88358361 |
| 56 | toxin metabolic process (GO:0009404) | 3.87402819 |
| 57 | fructose metabolic process (GO:0006000) | 3.87400581 |
| 58 | relaxation of cardiac muscle (GO:0055119) | 3.85189068 |
| 59 | terpenoid biosynthetic process (GO:0016114) | 3.84786743 |
| 60 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.84024200 |
| 61 | bone remodeling (GO:0046849) | 3.80853333 |
| 62 | GDP-mannose metabolic process (GO:0019673) | 3.76619881 |
| 63 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.73951670 |
| 64 | hormone catabolic process (GO:0042447) | 3.70844918 |
| 65 | regulation of superoxide anion generation (GO:0032928) | 3.65629651 |
| 66 | positive regulation of pseudopodium assembly (GO:0031274) | 3.61069926 |
| 67 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.59285015 |
| 68 | regulation of germinal center formation (GO:0002634) | 3.59189863 |
| 69 | epithelial cell-cell adhesion (GO:0090136) | 3.58140298 |
| 70 | sulfur amino acid catabolic process (GO:0000098) | 3.57635045 |
| 71 | heart valve morphogenesis (GO:0003179) | 3.52207635 |
| 72 | * regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.50451687 |
| 73 | * regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.50451687 |
| 74 | * endocrine process (GO:0050886) | 3.50451687 |
| 75 | drug metabolic process (GO:0017144) | 3.49254941 |
| 76 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.47767976 |
| 77 | phospholipid scrambling (GO:0017121) | 3.43608707 |
| 78 | relaxation of muscle (GO:0090075) | 3.43154422 |
| 79 | cardiac right ventricle morphogenesis (GO:0003215) | 3.38216181 |
| 80 | cellular response to interleukin-6 (GO:0071354) | 3.37148167 |
| 81 | outer ear morphogenesis (GO:0042473) | 3.35562442 |
| 82 | cranial nerve structural organization (GO:0021604) | 3.32579906 |
| 83 | protein retention in ER lumen (GO:0006621) | 3.32413392 |
| 84 | endocardial cushion morphogenesis (GO:0003203) | 3.32254699 |
| 85 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.32064718 |
| 86 | renal system process involved in regulation of blood volume (GO:0001977) | 3.27008507 |
| 87 | regulation of pseudopodium assembly (GO:0031272) | 3.24251947 |
| 88 | aorta morphogenesis (GO:0035909) | 3.21776331 |
| 89 | neurotransmitter biosynthetic process (GO:0042136) | 3.21647665 |
| 90 | regulation of vitamin metabolic process (GO:0030656) | 3.20775685 |
| 91 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.20346290 |
| 92 | adhesion of symbiont to host (GO:0044406) | 3.19962097 |
| 93 | nucleotide transmembrane transport (GO:1901679) | 3.19644623 |
| 94 | nephron epithelium morphogenesis (GO:0072088) | 3.18523655 |
| 95 | nephron tubule morphogenesis (GO:0072078) | 3.18523655 |
| 96 | COPI coating of Golgi vesicle (GO:0048205) | 3.12613167 |
| 97 | Golgi transport vesicle coating (GO:0048200) | 3.12613167 |
| 98 | histamine transport (GO:0051608) | 3.11463200 |
| 99 | * regulation of systemic arterial blood pressure (GO:0003073) | 3.11443461 |
| 100 | polarized epithelial cell differentiation (GO:0030859) | 3.10191367 |
| 101 | phenol-containing compound catabolic process (GO:0019336) | 3.09667586 |
| 102 | establishment of epithelial cell polarity (GO:0090162) | 3.07986233 |
| 103 | response to caffeine (GO:0031000) | 3.06344288 |
| 104 | myeloid leukocyte mediated immunity (GO:0002444) | 3.06068321 |
| 105 | auditory receptor cell stereocilium organization (GO:0060088) | 3.04540858 |
| 106 | actin filament depolymerization (GO:0030042) | 3.02074916 |
| 107 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.01839937 |
| 108 | glomerulus development (GO:0032835) | 3.00080634 |
| 109 | O-glycan processing (GO:0016266) | 2.99780647 |
| 110 | inner ear receptor cell differentiation (GO:0060113) | 2.98630809 |
| 111 | relaxation of smooth muscle (GO:0044557) | 2.97730093 |
| 112 | 4-hydroxyproline metabolic process (GO:0019471) | 2.96321259 |
| 113 | ganglion development (GO:0061548) | 2.96300974 |
| 114 | fat-soluble vitamin metabolic process (GO:0006775) | 2.95974664 |
| 115 | quaternary ammonium group transport (GO:0015697) | 2.95841707 |
| 116 | response to progesterone (GO:0032570) | 2.95520340 |
| 117 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.95046790 |
| 118 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.94739355 |
| 119 | negative regulation of axon guidance (GO:1902668) | 2.93723134 |
| 120 | peptide biosynthetic process (GO:0043043) | 2.92070929 |
| 121 | response to food (GO:0032094) | 2.91269279 |
| 122 | urea cycle (GO:0000050) | 2.90326183 |
| 123 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.89099966 |
| 124 | muscle cell cellular homeostasis (GO:0046716) | 2.86777171 |
| 125 | positive regulation of response to oxidative stress (GO:1902884) | 2.86715866 |
| 126 | positive regulation of cellular response to oxidative stress (GO:1900409) | 2.86715866 |
| 127 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.86558535 |
| 128 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.84345205 |
| 129 | morphogenesis of an epithelial sheet (GO:0002011) | 2.82841088 |
| 130 | axon extension involved in axon guidance (GO:0048846) | 2.82518561 |
| 131 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.82518561 |
| 132 | regulation of water loss via skin (GO:0033561) | 2.82299694 |
| 133 | glycoside metabolic process (GO:0016137) | 2.80598702 |
| 134 | virion attachment to host cell (GO:0019062) | 2.80027236 |
| 135 | adhesion of symbiont to host cell (GO:0044650) | 2.80027236 |
| 136 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.78198514 |
| 137 | xenobiotic metabolic process (GO:0006805) | 2.77588151 |
| 138 | establishment of apical/basal cell polarity (GO:0035089) | 2.77103005 |
| 139 | glycosylceramide metabolic process (GO:0006677) | 2.77048007 |
| 140 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.76574401 |
| 141 | oligosaccharide biosynthetic process (GO:0009312) | 2.76505971 |
| 142 | macroautophagy (GO:0016236) | 2.76135513 |
| 143 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.75957933 |
| 144 | primary alcohol catabolic process (GO:0034310) | 2.75490605 |
| 145 | negative regulation of JUN kinase activity (GO:0043508) | 2.74828782 |
| 146 | regulation of bile acid biosynthetic process (GO:0070857) | 2.74140223 |
| 147 | response to interleukin-6 (GO:0070741) | 2.74115090 |
| 148 | surfactant homeostasis (GO:0043129) | 2.72894365 |
| 149 | amide biosynthetic process (GO:0043604) | 2.71874076 |
| 150 | positive regulation of interleukin-8 secretion (GO:2000484) | 2.70416567 |
| 151 | response to dietary excess (GO:0002021) | 2.69595850 |
| 152 | glycolipid catabolic process (GO:0019377) | 2.68830963 |
| 153 | urea metabolic process (GO:0019627) | 2.68714336 |
| 154 | mesenchyme morphogenesis (GO:0072132) | 2.68674876 |
| 155 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.68444766 |
| 156 | glycosphingolipid catabolic process (GO:0046479) | 2.67681864 |
| 157 | neuronal stem cell maintenance (GO:0097150) | 2.66718924 |
| 158 | ear development (GO:0043583) | 2.66255110 |
| 159 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.65040966 |
| 160 | membrane lipid catabolic process (GO:0046466) | 2.64949237 |
| 161 | peptide hormone processing (GO:0016486) | 2.64115447 |
| 162 | peroxisome fission (GO:0016559) | 2.63719413 |
| 163 | membrane protein ectodomain proteolysis (GO:0006509) | 2.62928664 |
| 164 | negative regulation of chemokine production (GO:0032682) | 2.62798509 |
| 165 | ovulation cycle (GO:0042698) | 2.61972486 |
| 166 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.60980669 |
| 167 | cell adhesion mediated by integrin (GO:0033627) | 2.60335566 |
| 168 | sphingolipid catabolic process (GO:0030149) | 2.59663474 |
| 169 | multicellular organismal water homeostasis (GO:0050891) | 2.59368211 |
| 170 | polyketide metabolic process (GO:0030638) | 2.58866262 |
| 171 | doxorubicin metabolic process (GO:0044598) | 2.58866262 |
| 172 | daunorubicin metabolic process (GO:0044597) | 2.58866262 |
| 173 | hydrogen peroxide catabolic process (GO:0042744) | 2.57284771 |
| 174 | hemidesmosome assembly (GO:0031581) | 2.57240991 |
| 175 | negative regulation of metanephros development (GO:0072217) | 2.55056658 |
| 176 | establishment of skin barrier (GO:0061436) | 2.54083756 |
| 177 | copper ion transport (GO:0006825) | 2.53901633 |
| 178 | positive regulation of steroid biosynthetic process (GO:0010893) | 2.53459321 |
| 179 | negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037) | 2.52690150 |
| 180 | reactive oxygen species biosynthetic process (GO:1903409) | 2.51503955 |
| 181 | tight junction assembly (GO:0070830) | 2.50762411 |
| 182 | xenobiotic catabolic process (GO:0042178) | 13.1491997 |
| 183 | response to nitrosative stress (GO:0051409) | 12.9929025 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.40046520 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 5.51167612 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.59830162 |
| 4 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.52630960 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.01718501 |
| 6 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.84467854 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.83464453 |
| 8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.66502420 |
| 9 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.39169488 |
| 10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.35551552 |
| 11 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.22769835 |
| 12 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 2.21869506 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.06223200 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.99438460 |
| 15 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.99245166 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.94022701 |
| 17 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.89873730 |
| 18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.84108621 |
| 19 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.80089708 |
| 20 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.77644796 |
| 21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.76443079 |
| 22 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.67204030 |
| 23 | RXR_22108803_ChIP-Seq_LS180_Human | 1.67169939 |
| 24 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.65878388 |
| 25 | ATF3_27146783_Chip-Seq_COLON_Human | 1.64821337 |
| 26 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.62738386 |
| 27 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.62738386 |
| 28 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.59279164 |
| 29 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.57862788 |
| 30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56540013 |
| 31 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.50748814 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.50194785 |
| 33 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.49875978 |
| 34 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.47501863 |
| 35 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.46305318 |
| 36 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.44799277 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43600732 |
| 38 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.43319723 |
| 39 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.42921447 |
| 40 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42753415 |
| 41 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.41677185 |
| 42 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.39999720 |
| 43 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.38050660 |
| 44 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.37223483 |
| 45 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.36612524 |
| 46 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.36612524 |
| 47 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.36458876 |
| 48 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.35966966 |
| 49 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.35062271 |
| 50 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.33499786 |
| 51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.31131847 |
| 52 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29084234 |
| 53 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28135315 |
| 54 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.27526594 |
| 55 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.26668527 |
| 56 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.26281145 |
| 57 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.26068866 |
| 58 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.25726428 |
| 59 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.23659904 |
| 60 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.22243381 |
| 61 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.19506870 |
| 62 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.19310025 |
| 63 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.18148284 |
| 64 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.14269894 |
| 65 | CJUN_26792858_Chip-Seq_BT549_Human | 1.14250960 |
| 66 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.14050997 |
| 67 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13363259 |
| 68 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.11712904 |
| 69 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.11216238 |
| 70 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.10285217 |
| 71 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.09590700 |
| 72 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.09590700 |
| 73 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.09099781 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08848107 |
| 75 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08108176 |
| 76 | * EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.06824454 |
| 77 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.06220289 |
| 78 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.06170697 |
| 79 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05359249 |
| 80 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.05302428 |
| 81 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.03499105 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02573561 |
| 83 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.02553398 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.02117645 |
| 85 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.01470906 |
| 86 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.01470474 |
| 87 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01266546 |
| 88 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.00999261 |
| 89 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.99774445 |
| 90 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.99076297 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.98667684 |
| 92 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97656502 |
| 93 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.97130347 |
| 94 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.96953583 |
| 95 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96835799 |
| 96 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96813069 |
| 97 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.96400235 |
| 98 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.94788951 |
| 99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.94405362 |
| 100 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.93798408 |
| 101 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.93172296 |
| 102 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.91915296 |
| 103 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.91641590 |
| 104 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.90767907 |
| 105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90461740 |
| 106 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.90216402 |
| 107 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.89539124 |
| 108 | * TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.89398121 |
| 109 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.89382517 |
| 110 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.89033977 |
| 111 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88351819 |
| 112 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.87998635 |
| 113 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.86726151 |
| 114 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.86661628 |
| 115 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86520931 |
| 116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85959262 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85295336 |
| 118 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.84940144 |
| 119 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.84786719 |
| 120 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83766565 |
| 121 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.83660461 |
| 122 | GATA1_22025678_ChIP-Seq_K562_Human | 0.83496474 |
| 123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.82812538 |
| 124 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.82555580 |
| 125 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82327934 |
| 126 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.82078518 |
| 127 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.81808897 |
| 128 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.81470625 |
| 129 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.81014593 |
| 130 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.80489718 |
| 131 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.80305739 |
| 132 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.80132191 |
| 133 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.80084096 |
| 134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.79742849 |
| 135 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.79163619 |
| 136 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77978162 |
| 137 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.77618843 |
| 138 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.75873555 |
| 139 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.75301373 |
| 140 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.74941601 |
| 141 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.74869225 |
| 142 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.73197853 |
| 143 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.72143394 |
| 144 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.72074659 |
| 145 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.71772711 |
| 146 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.71546585 |
| 147 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.71501772 |
| 148 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70287044 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008789_abnormal_olfactory_epithelium | 6.17398445 |
| 2 | MP0005394_taste/olfaction_phenotype | 5.90787846 |
| 3 | MP0005499_abnormal_olfactory_system | 5.90787846 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 4.05002365 |
| 5 | MP0010234_abnormal_vibrissa_follicle | 3.78802714 |
| 6 | MP0009053_abnormal_anal_canal | 3.32535915 |
| 7 | MP0002132_abnormal_respiratory_system | 3.32367249 |
| 8 | MP0009840_abnormal_foam_cell | 3.13304438 |
| 9 | MP0002139_abnormal_hepatobiliary_system | 3.00246274 |
| 10 | MP0003453_abnormal_keratinocyte_physiol | 2.77422403 |
| 11 | MP0010030_abnormal_orbit_morphology | 2.76810981 |
| 12 | MP0005377_hearing/vestibular/ear_phenot | 2.58335596 |
| 13 | MP0003878_abnormal_ear_physiology | 2.58335596 |
| 14 | MP0001984_abnormal_olfaction | 2.57685106 |
| 15 | MP0004381_abnormal_hair_follicle | 2.56672320 |
| 16 | MP0002233_abnormal_nose_morphology | 2.54484585 |
| 17 | MP0003183_abnormal_peptide_metabolism | 2.53790564 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.42744341 |
| 19 | MP0002877_abnormal_melanocyte_morpholog | 2.37789859 |
| 20 | MP0000566_synostosis | 2.19926700 |
| 21 | MP0002098_abnormal_vibrissa_morphology | 2.19282009 |
| 22 | MP0000762_abnormal_tongue_morphology | 2.16597790 |
| 23 | MP0000538_abnormal_urinary_bladder | 2.09233093 |
| 24 | MP0003186_abnormal_redox_activity | 2.02894042 |
| 25 | MP0000537_abnormal_urethra_morphology | 1.99692498 |
| 26 | MP0005332_abnormal_amino_acid | 1.95855251 |
| 27 | MP0005085_abnormal_gallbladder_physiolo | 1.95053344 |
| 28 | MP0000467_abnormal_esophagus_morphology | 1.87266859 |
| 29 | MP0002138_abnormal_hepatobiliary_system | 1.84198754 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.82243519 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.77201948 |
| 32 | MP0004782_abnormal_surfactant_physiolog | 1.72998826 |
| 33 | MP0005451_abnormal_body_composition | 1.71211282 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.70476764 |
| 35 | MP0009643_abnormal_urine_homeostasis | 1.70350532 |
| 36 | MP0004272_abnormal_basement_membrane | 1.68060132 |
| 37 | MP0002796_impaired_skin_barrier | 1.67818453 |
| 38 | MP0005187_abnormal_penis_morphology | 1.67007377 |
| 39 | MP0000678_abnormal_parathyroid_gland | 1.63224822 |
| 40 | MP0001664_abnormal_digestion | 1.61851361 |
| 41 | MP0001765_abnormal_ion_homeostasis | 1.60760189 |
| 42 | MP0000049_abnormal_middle_ear | 1.57686872 |
| 43 | MP0001501_abnormal_sleep_pattern | 1.56154531 |
| 44 | MP0009379_abnormal_foot_pigmentation | 1.55682023 |
| 45 | MP0010386_abnormal_urinary_bladder | 1.54013449 |
| 46 | MP0002060_abnormal_skin_morphology | 1.53336011 |
| 47 | MP0003252_abnormal_bile_duct | 1.51359915 |
| 48 | MP0003941_abnormal_skin_development | 1.49615245 |
| 49 | MP0000490_abnormal_crypts_of | 1.44495542 |
| 50 | MP0008872_abnormal_physiological_respon | 1.43974948 |
| 51 | MP0009250_abnormal_appendicular_skeleto | 1.41685378 |
| 52 | MP0003136_yellow_coat_color | 1.41613972 |
| 53 | MP0004510_myositis | 1.36538947 |
| 54 | MP0001851_eye_inflammation | 1.36321957 |
| 55 | MP0000377_abnormal_hair_follicle | 1.35824188 |
| 56 | MP0003566_abnormal_cell_adhesion | 1.35264213 |
| 57 | MP0002136_abnormal_kidney_physiology | 1.34012081 |
| 58 | MP0010678_abnormal_skin_adnexa | 1.32004970 |
| 59 | MP0000465_gastrointestinal_hemorrhage | 1.30439516 |
| 60 | MP0002249_abnormal_larynx_morphology | 1.30074349 |
| 61 | MP0000477_abnormal_intestine_morphology | 1.28122246 |
| 62 | MP0006292_abnormal_olfactory_placode | 1.28024884 |
| 63 | MP0002928_abnormal_bile_duct | 1.27255952 |
| 64 | MP0002166_altered_tumor_susceptibility | 1.24197056 |
| 65 | MP0001873_stomach_inflammation | 1.21561974 |
| 66 | MP0003866_abnormal_defecation | 1.21412223 |
| 67 | MP0005360_urolithiasis | 1.20240990 |
| 68 | MP0000003_abnormal_adipose_tissue | 1.19680273 |
| 69 | MP0004947_skin_inflammation | 1.16532208 |
| 70 | MP0002090_abnormal_vision | 1.15847659 |
| 71 | MP0005670_abnormal_white_adipose | 1.13280918 |
| 72 | MP0005166_decreased_susceptibility_to | 1.10111760 |
| 73 | MP0005084_abnormal_gallbladder_morpholo | 1.09814901 |
| 74 | MP0001216_abnormal_epidermal_layer | 1.08496609 |
| 75 | MP0005365_abnormal_bile_salt | 1.08473225 |
| 76 | MP0008260_abnormal_autophagy | 1.08159026 |
| 77 | MP0000613_abnormal_salivary_gland | 1.07729318 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 1.06677288 |
| 79 | MP0000534_abnormal_ureter_morphology | 1.06617623 |
| 80 | MP0003868_abnormal_feces_composition | 1.05110058 |
| 81 | MP0001346_abnormal_lacrimal_gland | 1.04161761 |
| 82 | MP0002234_abnormal_pharynx_morphology | 1.03002725 |
| 83 | MP0003879_abnormal_hair_cell | 1.02305034 |
| 84 | MP0003693_abnormal_embryo_hatching | 1.01778319 |
| 85 | MP0004147_increased_porphyrin_level | 1.01052568 |
| 86 | MP0002277_abnormal_respiratory_mucosa | 0.96552730 |
| 87 | MP0003943_abnormal_hepatobiliary_system | 0.96191662 |
| 88 | MP0001756_abnormal_urination | 0.96098660 |
| 89 | MP0005501_abnormal_skin_physiology | 0.94746736 |
| 90 | MP0005319_abnormal_enzyme/_coenzyme | 0.94377843 |
| 91 | MP0004858_abnormal_nervous_system | 0.93893110 |
| 92 | MP0001881_abnormal_mammary_gland | 0.92849458 |
| 93 | MP0004043_abnormal_pH_regulation | 0.92829049 |
| 94 | MP0002177_abnormal_outer_ear | 0.91773534 |
| 95 | MP0002006_tumorigenesis | 0.91620141 |
| 96 | MP0000609_abnormal_liver_physiology | 0.91398307 |
| 97 | MP0005408_hypopigmentation | 0.91079653 |
| 98 | MP0009785_altered_susceptibility_to | 0.89270887 |
| 99 | MP0001905_abnormal_dopamine_level | 0.88186145 |
| 100 | MP0001177_atelectasis | 0.87184543 |
| 101 | MP0005330_cardiomyopathy | 0.86745478 |
| 102 | MP0005197_abnormal_uvea_morphology | 0.85515806 |
| 103 | MP0003755_abnormal_palate_morphology | 0.85037508 |
| 104 | MP0003300_gastrointestinal_ulcer | 0.83386953 |
| 105 | MP0003315_abnormal_perineum_morphology | 0.81607855 |
| 106 | MP0000627_abnormal_mammary_gland | 0.80104738 |
| 107 | MP0005409_darkened_coat_color | 0.79830238 |
| 108 | MP0002295_abnormal_pulmonary_circulatio | 0.79653309 |
| 109 | MP0006082_CNS_inflammation | 0.79497640 |
| 110 | MP0003937_abnormal_limbs/digits/tail_de | 0.78689204 |
| 111 | MP0003942_abnormal_urinary_system | 0.78107007 |
| 112 | MP0003718_maternal_effect | 0.77411853 |
| 113 | MP0010329_abnormal_lipoprotein_level | 0.77244287 |
| 114 | MP0003436_decreased_susceptibility_to | 0.76590934 |
| 115 | MP0001853_heart_inflammation | 0.76133195 |
| 116 | MP0009780_abnormal_chondrocyte_physiolo | 0.75938020 |
| 117 | MP0002118_abnormal_lipid_homeostasis | 0.75380322 |
| 118 | MP0000383_abnormal_hair_follicle | 0.75323305 |
| 119 | MP0001340_abnormal_eyelid_morphology | 0.74826756 |
| 120 | MP0010771_integument_phenotype | 0.74626340 |
| 121 | MP0003724_increased_susceptibility_to | 0.74555286 |
| 122 | MP0002254_reproductive_system_inflammat | 0.74322750 |
| 123 | MP0002133_abnormal_respiratory_system | 0.71572188 |
| 124 | MP0005388_respiratory_system_phenotype | 0.71572188 |
| 125 | MP0003690_abnormal_glial_cell | 0.70324040 |
| 126 | MP0005164_abnormal_response_to | 0.70233208 |
| 127 | MP0005023_abnormal_wound_healing | 0.69788400 |
| 128 | MP0004264_abnormal_extraembryonic_tissu | 0.69524500 |
| 129 | MP0003385_abnormal_body_wall | 0.68847750 |
| 130 | MP0005375_adipose_tissue_phenotype | 0.67535700 |
| 131 | MP0003938_abnormal_ear_development | 0.67521465 |
| 132 | MP0003828_pulmonary_edema | 0.66849289 |
| 133 | MP0006138_congestive_heart_failure | 0.66639109 |
| 134 | MP0004134_abnormal_chest_morphology | 0.65775166 |
| 135 | MP0009765_abnormal_xenobiotic_induced | 0.65145515 |
| 136 | MP0002896_abnormal_bone_mineralization | 0.64833350 |
| 137 | MP0005076_abnormal_cell_differentiation | 0.64397800 |
| 138 | MP0001764_abnormal_homeostasis | 0.64125310 |
| 139 | MP0000163_abnormal_cartilage_morphology | 0.63611869 |
| 140 | MP0010352_gastrointestinal_tract_polyps | 0.62552128 |
| 141 | MP0001919_abnormal_reproductive_system | 0.62431728 |
| 142 | MP0002009_preneoplasia | 0.61747725 |
| 143 | MP0003091_abnormal_cell_migration | 0.59520970 |
| 144 | MP0005165_increased_susceptibility_to | 0.59347476 |
| 145 | MP0000372_irregular_coat_pigmentation | 0.59247387 |
| 146 | MP0001666_abnormal_nutrient_absorption | 0.59071337 |
| 147 | MP0002653_abnormal_ependyma_morphology | 0.59008691 |
| 148 | MP0003705_abnormal_hypodermis_morpholog | 0.58667183 |
| 149 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.58172217 |
| 150 | MP0009764_decreased_sensitivity_to | 0.57729686 |
| 151 | MP0000462_abnormal_digestive_system | 0.57302176 |
| 152 | MP0002092_abnormal_eye_morphology | 0.57254652 |
| 153 | MP0000579_abnormal_nail_morphology | 0.56938672 |
| 154 | MP0009931_abnormal_skin_appearance | 0.56928859 |
| 155 | MP0005248_abnormal_Harderian_gland | 0.56301311 |
| 156 | MP0002135_abnormal_kidney_morphology | 0.55953479 |
| 157 | MP0005508_abnormal_skeleton_morphology | 0.55309569 |
| 158 | MP0000858_altered_metastatic_potential | 0.55269020 |
| 159 | MP0008438_abnormal_cutaneous_collagen | 0.53597915 |
| 160 | MP0004019_abnormal_vitamin_homeostasis | 0.53588062 |
| 161 | MP0005381_digestive/alimentary_phenotyp | 0.53359754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 8.75431222 |
| 2 | Stomach cancer (HP:0012126) | 8.37868615 |
| 3 | Hydroxyprolinuria (HP:0003080) | 6.96821322 |
| 4 | Abnormality of proline metabolism (HP:0010907) | 6.96821322 |
| 5 | Lip pit (HP:0100267) | 6.40389442 |
| 6 | Prostate neoplasm (HP:0100787) | 5.85941165 |
| 7 | Malnutrition (HP:0004395) | 5.78853986 |
| 8 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 4.78342740 |
| 9 | Vascular calcification (HP:0004934) | 4.51309782 |
| 10 | Popliteal pterygium (HP:0009756) | 4.44325318 |
| 11 | Renal tubular acidosis (HP:0001947) | 4.38305678 |
| 12 | Bifid scrotum (HP:0000048) | 4.34689840 |
| 13 | Alopecia of scalp (HP:0002293) | 4.20994232 |
| 14 | Abnormal hemoglobin (HP:0011902) | 4.17741072 |
| 15 | Aplasia involving bones of the upper limbs (HP:0009823) | 4.16149209 |
| 16 | Aplasia of the phalanges of the hand (HP:0009802) | 4.16149209 |
| 17 | Aplasia involving bones of the extremities (HP:0009825) | 4.16149209 |
| 18 | Cardiovascular calcification (HP:0011915) | 4.08281091 |
| 19 | Hyperphosphatemia (HP:0002905) | 4.06576510 |
| 20 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.90987634 |
| 21 | Stenosis of the external auditory canal (HP:0000402) | 3.82551835 |
| 22 | Steatorrhea (HP:0002570) | 3.80706097 |
| 23 | Alveolar cell carcinoma (HP:0006519) | 3.74361266 |
| 24 | Preauricular pit (HP:0004467) | 3.57953090 |
| 25 | Periauricular skin pits (HP:0100277) | 3.57953090 |
| 26 | Chorioretinal atrophy (HP:0000533) | 3.56201766 |
| 27 | Abnormality of the distal phalanges of the toes (HP:0010182) | 3.54873383 |
| 28 | Hypoplastic labia majora (HP:0000059) | 3.53015031 |
| 29 | Fat malabsorption (HP:0002630) | 3.49947924 |
| 30 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.48552087 |
| 31 | Neoplasm of the tracheobronchial system (HP:0100552) | 3.42242372 |
| 32 | Tetraparesis (HP:0002273) | 3.32399624 |
| 33 | Absent eyebrow (HP:0002223) | 3.28360483 |
| 34 | Ileus (HP:0002595) | 3.23889774 |
| 35 | Vertebral compression fractures (HP:0002953) | 3.23676484 |
| 36 | Abnormality of the labia majora (HP:0012881) | 3.20887502 |
| 37 | Thin bony cortex (HP:0002753) | 3.16666117 |
| 38 | Focal segmental glomerulosclerosis (HP:0000097) | 3.14256769 |
| 39 | Abnormality of the middle phalanges of the toes (HP:0010183) | 3.11262260 |
| 40 | Hypoplastic scapulae (HP:0000882) | 3.10829181 |
| 41 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 3.10829181 |
| 42 | Skin pits (HP:0100276) | 3.01075499 |
| 43 | Hypoplasia of the uterus (HP:0000013) | 3.00224734 |
| 44 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.98586885 |
| 45 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.98586885 |
| 46 | Distal lower limb muscle weakness (HP:0009053) | 2.92212260 |
| 47 | Abdominal distention (HP:0003270) | 2.89012158 |
| 48 | Confusion (HP:0001289) | 2.87759536 |
| 49 | Right ventricular cardiomyopathy (HP:0011663) | 2.84553583 |
| 50 | Potter facies (HP:0002009) | 2.75752702 |
| 51 | Facial shape deformation (HP:0011334) | 2.75752702 |
| 52 | Rickets (HP:0002748) | 2.72014202 |
| 53 | Short hallux (HP:0010109) | 2.71000950 |
| 54 | Pulmonary artery stenosis (HP:0004415) | 2.70847433 |
| 55 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.64007009 |
| 56 | Hypoplasia of dental enamel (HP:0006297) | 2.62599723 |
| 57 | Chronic diarrhea (HP:0002028) | 2.62446516 |
| 58 | Morphological abnormality of the middle ear (HP:0008609) | 2.62406922 |
| 59 | Labial hypoplasia (HP:0000066) | 2.61749415 |
| 60 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.61464538 |
| 61 | Fibular aplasia (HP:0002990) | 2.61440522 |
| 62 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.59546472 |
| 63 | Renal dysplasia (HP:0000110) | 2.57044458 |
| 64 | Cupped ear (HP:0000378) | 2.56309196 |
| 65 | Pterygium (HP:0001059) | 2.53197405 |
| 66 | Ulnar claw (HP:0001178) | 2.51494065 |
| 67 | Villous atrophy (HP:0011473) | 2.50678998 |
| 68 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.50678998 |
| 69 | Sleep apnea (HP:0010535) | 2.49750799 |
| 70 | Gout (HP:0001997) | 2.49366110 |
| 71 | Abnormal tarsal ossification (HP:0008369) | 2.48490759 |
| 72 | Abnormality of the prostate (HP:0008775) | 2.48205858 |
| 73 | Papillary thyroid carcinoma (HP:0002895) | 2.47897399 |
| 74 | Hyperammonemia (HP:0001987) | 2.45664471 |
| 75 | Dysphonia (HP:0001618) | 2.44669964 |
| 76 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.44554708 |
| 77 | Glomerulosclerosis (HP:0000096) | 2.44347986 |
| 78 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.42901599 |
| 79 | Palpitations (HP:0001962) | 2.40211924 |
| 80 | Hypoplastic female external genitalia (HP:0012815) | 2.39871965 |
| 81 | Abnormality of urine glucose concentration (HP:0011016) | 2.37785479 |
| 82 | Glycosuria (HP:0003076) | 2.37785479 |
| 83 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.37637986 |
| 84 | Down-sloping shoulders (HP:0200021) | 2.36635172 |
| 85 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.36549553 |
| 86 | Nasolacrimal duct obstruction (HP:0000579) | 2.35438273 |
| 87 | Pigmentary retinal degeneration (HP:0001146) | 2.35371252 |
| 88 | Sparse eyelashes (HP:0000653) | 2.34639432 |
| 89 | Renal tubular dysfunction (HP:0000124) | 2.33759814 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 2.33750039 |
| 91 | Abnormality of the 2nd finger (HP:0004100) | 2.33628429 |
| 92 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.29788013 |
| 93 | Absent eyelashes (HP:0000561) | 2.28368882 |
| 94 | Nephrolithiasis (HP:0000787) | 2.28072512 |
| 95 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.27974444 |
| 96 | Proximal tubulopathy (HP:0000114) | 2.27710370 |
| 97 | Prolonged neonatal jaundice (HP:0006579) | 2.27695607 |
| 98 | Widely patent fontanelles and sutures (HP:0004492) | 2.26837381 |
| 99 | Reduced antithrombin III activity (HP:0001976) | 2.26177604 |
| 100 | Abnormality of cochlea (HP:0000375) | 2.25158816 |
| 101 | Hypoplasia of the ulna (HP:0003022) | 2.24552455 |
| 102 | Upper limb amyotrophy (HP:0009129) | 2.24452612 |
| 103 | Distal upper limb amyotrophy (HP:0007149) | 2.24452612 |
| 104 | Progressive sensorineural hearing impairment (HP:0000408) | 2.23456697 |
| 105 | Flat acetabular roof (HP:0003180) | 2.22926385 |
| 106 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.22914580 |
| 107 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.22097184 |
| 108 | Taurodontia (HP:0000679) | 2.21348331 |
| 109 | Abnormality of permanent molar morphology (HP:0011071) | 2.21348331 |
| 110 | Abnormality of the dental root (HP:0006486) | 2.21348331 |
| 111 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.21220248 |
| 112 | Increased purine levels (HP:0004368) | 2.18709319 |
| 113 | Hyperuricemia (HP:0002149) | 2.18709319 |
| 114 | Xanthomatosis (HP:0000991) | 2.18436297 |
| 115 | Hypobetalipoproteinemia (HP:0003563) | 2.17347568 |
| 116 | Upper limb muscle weakness (HP:0003484) | 2.16609092 |
| 117 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.16530274 |
| 118 | Abnormality of vitamin B metabolism (HP:0004340) | 2.16508120 |
| 119 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.16186281 |
| 120 | Absent toe (HP:0010760) | 2.15078906 |
| 121 | Vertebral arch anomaly (HP:0008438) | 2.14784323 |
| 122 | Paraparesis (HP:0002385) | 2.14364669 |
| 123 | Ridged nail (HP:0001807) | 2.11437697 |
| 124 | Hepatocellular carcinoma (HP:0001402) | 2.10075639 |
| 125 | Dicarboxylic aciduria (HP:0003215) | 2.09071895 |
| 126 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.09071895 |
| 127 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.07191095 |
| 128 | Abnormality of the renal collecting system (HP:0004742) | 2.06640589 |
| 129 | Hand muscle atrophy (HP:0009130) | 2.05183498 |
| 130 | Hepatoblastoma (HP:0002884) | 2.04837429 |
| 131 | Abnormality of molar (HP:0011077) | 2.04666765 |
| 132 | Abnormality of molar morphology (HP:0011070) | 2.04666765 |
| 133 | Corneal erosion (HP:0200020) | 2.04393497 |
| 134 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.03956680 |
| 135 | Split foot (HP:0001839) | 2.03754880 |
| 136 | Nausea (HP:0002018) | 2.02999836 |
| 137 | Hyperparathyroidism (HP:0000843) | 2.00608064 |
| 138 | Abnormality of vitamin metabolism (HP:0100508) | 1.99911772 |
| 139 | Plantar hyperkeratosis (HP:0007556) | 1.98406378 |
| 140 | Abnormality of the corticospinal tract (HP:0002492) | 1.98166935 |
| 141 | Congenital, generalized hypertrichosis (HP:0004540) | 1.97886753 |
| 142 | Gastrointestinal dysmotility (HP:0002579) | 1.96959446 |
| 143 | Abnormality of the labia (HP:0000058) | 1.96943516 |
| 144 | Neoplasm of the adrenal cortex (HP:0100641) | 1.94317335 |
| 145 | Hyperglycinuria (HP:0003108) | 1.92896140 |
| 146 | Ventricular tachycardia (HP:0004756) | 1.92771401 |
| 147 | Asymmetric septal hypertrophy (HP:0001670) | 1.90919090 |
| 148 | Pseudobulbar signs (HP:0002200) | 1.89909502 |
| 149 | Follicular hyperkeratosis (HP:0007502) | 1.88461281 |
| 150 | Cupped ribs (HP:0000887) | 1.88293759 |
| 151 | Mixed hearing impairment (HP:0000410) | 1.87574650 |
| 152 | Anterior segment dysgenesis (HP:0007700) | 1.87292364 |
| 153 | Morphological abnormality of the inner ear (HP:0011390) | 1.87116292 |
| 154 | Abnormality of the dental pulp (HP:0006479) | 1.86828956 |
| 155 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.86082243 |
| 156 | Bone pain (HP:0002653) | 1.85476780 |
| 157 | Abnormality of the lacrimal duct (HP:0011481) | 1.85313735 |
| 158 | Elevated alkaline phosphatase (HP:0003155) | 1.83886847 |
| 159 | Acanthosis nigricans (HP:0000956) | 1.83247494 |
| 160 | Subcapsular cataract (HP:0000523) | 1.83094867 |
| 161 | Abnormality of the anterior horn cell (HP:0006802) | 1.82897610 |
| 162 | Degeneration of anterior horn cells (HP:0002398) | 1.82897610 |
| 163 | Milia (HP:0001056) | 1.82717334 |
| 164 | Wide cranial sutures (HP:0010537) | 1.81498782 |
| 165 | Nephritis (HP:0000123) | 1.81314661 |
| 166 | Pruritus (HP:0000989) | 1.81057705 |
| 167 | Abnormal glucose tolerance (HP:0001952) | 1.80482100 |
| 168 | Micronodular cirrhosis (HP:0001413) | 1.78540790 |
| 169 | Woolly hair (HP:0002224) | 1.78452507 |
| 170 | Spinal rigidity (HP:0003306) | 1.78152406 |
| 171 | Vertebral hypoplasia (HP:0008417) | 1.77687729 |
| 172 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.77687729 |
| 173 | Abnormality of macular pigmentation (HP:0008002) | 1.77382931 |
| 174 | Axonal loss (HP:0003447) | 1.77289737 |
| 175 | Mucopolysacchariduria (HP:0008155) | 1.77125795 |
| 176 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.77125795 |
| 177 | Hyperactive renin-angiotensin system (HP:0000841) | 1.74032850 |
| 178 | Hypophosphatemia (HP:0002148) | 1.73826156 |
| 179 | Hypotrichosis (HP:0001006) | 1.73763934 |
| 180 | Abnormality of renal resorption (HP:0011038) | 1.70767516 |
| 181 | Abnormal hair laboratory examination (HP:0003328) | 1.69974868 |
| 182 | Increased CSF protein (HP:0002922) | 1.69757117 |
| 183 | Abnormality of nail color (HP:0100643) | 1.69398864 |
| 184 | Abnormal trabecular bone morphology (HP:0100671) | 1.69171177 |
| 185 | Pili torti (HP:0003777) | 1.68657194 |
| 186 | Abnormal urine phosphate concentration (HP:0012599) | 1.66769195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K3 | 5.53945528 |
| 2 | MAP2K3 | 3.72240232 |
| 3 | MAP3K2 | 3.39460279 |
| 4 | MAP3K14 | 3.30374780 |
| 5 | RPS6KA4 | 3.23797018 |
| 6 | MST4 | 3.11863035 |
| 7 | MAPK15 | 2.91464117 |
| 8 | RPS6KB2 | 2.64411067 |
| 9 | ZAK | 2.55705213 |
| 10 | MAP2K6 | 2.21687313 |
| 11 | PBK | 2.11295701 |
| 12 | EPHA2 | 2.07809036 |
| 13 | ERBB3 | 2.07523007 |
| 14 | BCKDK | 2.03284643 |
| 15 | FRK | 2.02466424 |
| 16 | MYLK | 2.02064868 |
| 17 | SMG1 | 1.99768415 |
| 18 | TESK1 | 1.91109613 |
| 19 | FER | 1.91025333 |
| 20 | GRK6 | 1.85215785 |
| 21 | MAP3K11 | 1.82684939 |
| 22 | RIPK1 | 1.77204891 |
| 23 | MAP2K4 | 1.71918535 |
| 24 | LATS1 | 1.66666272 |
| 25 | NME1 | 1.62172833 |
| 26 | MAP2K2 | 1.60858021 |
| 27 | MET | 1.58975078 |
| 28 | ACVR1B | 1.56415680 |
| 29 | TNIK | 1.55917959 |
| 30 | MAP3K6 | 1.55563337 |
| 31 | EPHB2 | 1.52013826 |
| 32 | TAOK2 | 1.50354100 |
| 33 | EPHA3 | 1.50208759 |
| 34 | IKBKE | 1.47474772 |
| 35 | SIK3 | 1.47288452 |
| 36 | PAK4 | 1.44775821 |
| 37 | TAOK1 | 1.42271426 |
| 38 | MKNK2 | 1.41007358 |
| 39 | BMPR2 | 1.38932100 |
| 40 | NEK6 | 1.30578700 |
| 41 | TRPM7 | 1.29590896 |
| 42 | NLK | 1.27701135 |
| 43 | STK4 | 1.23823971 |
| 44 | IRAK3 | 1.22758264 |
| 45 | HIPK2 | 1.22638000 |
| 46 | DAPK1 | 1.18918563 |
| 47 | PDK2 | 1.16726694 |
| 48 | PTK2 | 1.15928387 |
| 49 | ADRBK2 | 1.13816771 |
| 50 | STK38 | 1.10541388 |
| 51 | EPHB1 | 1.10478782 |
| 52 | VRK2 | 1.06367282 |
| 53 | SIK1 | 1.05347585 |
| 54 | LIMK1 | 1.02786143 |
| 55 | ABL2 | 1.00960589 |
| 56 | PIM2 | 0.98584275 |
| 57 | MAP2K1 | 0.98024889 |
| 58 | MAPKAPK3 | 0.97224290 |
| 59 | MAPK12 | 0.95012153 |
| 60 | PRPF4B | 0.92344288 |
| 61 | BCR | 0.92175253 |
| 62 | TRIB3 | 0.89174010 |
| 63 | CAMK4 | 0.88872368 |
| 64 | MAPK7 | 0.87258873 |
| 65 | ILK | 0.86893266 |
| 66 | IKBKB | 0.86857845 |
| 67 | CSNK1A1L | 0.86151353 |
| 68 | NEK1 | 0.84929769 |
| 69 | TBK1 | 0.84884990 |
| 70 | MAP3K12 | 0.83163774 |
| 71 | CHUK | 0.82741812 |
| 72 | DAPK3 | 0.81350541 |
| 73 | TTN | 0.79934235 |
| 74 | MST1R | 0.76502499 |
| 75 | TESK2 | 0.75280402 |
| 76 | MKNK1 | 0.73344758 |
| 77 | PRKD2 | 0.72914915 |
| 78 | RPS6KA5 | 0.70862432 |
| 79 | LRRK2 | 0.70494267 |
| 80 | CDK3 | 0.68767834 |
| 81 | PRKCI | 0.66661100 |
| 82 | PAK3 | 0.65320266 |
| 83 | ERBB4 | 0.64245483 |
| 84 | DDR2 | 0.61065040 |
| 85 | PDPK1 | 0.60564049 |
| 86 | RPS6KA6 | 0.59266207 |
| 87 | STK10 | 0.59013666 |
| 88 | NME2 | 0.57752439 |
| 89 | YES1 | 0.56774806 |
| 90 | BMX | 0.56376650 |
| 91 | MAP3K5 | 0.56275063 |
| 92 | PRKG2 | 0.53832545 |
| 93 | MAP3K1 | 0.53103991 |
| 94 | RIPK4 | 0.52886765 |
| 95 | PRKCE | 0.52410814 |
| 96 | CDK6 | 0.51796327 |
| 97 | MAP3K8 | 0.51079485 |
| 98 | MAPKAPK5 | 0.50027023 |
| 99 | LMTK2 | 0.49484397 |
| 100 | AKT2 | 0.49473598 |
| 101 | GRK5 | 0.49296186 |
| 102 | CLK1 | 0.49048191 |
| 103 | CDC42BPA | 0.48624120 |
| 104 | TAF1 | 0.48407914 |
| 105 | IRAK2 | 0.48137529 |
| 106 | ERN1 | 0.46950780 |
| 107 | CAMK2B | 0.45414453 |
| 108 | ARAF | 0.45344387 |
| 109 | MAP3K10 | 0.44155779 |
| 110 | CAMK2D | 0.43724565 |
| 111 | EIF2AK1 | 0.43083001 |
| 112 | TYK2 | 0.42911150 |
| 113 | TRIM28 | 0.42002257 |
| 114 | PINK1 | 0.41701304 |
| 115 | CAMK1 | 0.40955244 |
| 116 | MAPKAPK2 | 0.40155659 |
| 117 | IRAK1 | 0.40042875 |
| 118 | PIK3CA | 0.39261607 |
| 119 | MAP3K4 | 0.39134597 |
| 120 | CDK4 | 0.39011897 |
| 121 | LATS2 | 0.37863650 |
| 122 | PIM1 | 0.37727265 |
| 123 | MATK | 0.36889928 |
| 124 | SRC | 0.35867405 |
| 125 | ERBB2 | 0.34760424 |
| 126 | RPS6KA2 | 0.34260262 |
| 127 | PRKCQ | 0.34046884 |
| 128 | FGFR4 | 0.33300553 |
| 129 | AURKA | 0.33263307 |
| 130 | CSNK1G3 | 0.32739012 |
| 131 | CDK9 | 0.32155922 |
| 132 | ROCK1 | 0.31502025 |
| 133 | PDGFRA | 0.31484616 |
| 134 | CDK7 | 0.31275755 |
| 135 | CAMK2G | 0.30989478 |
| 136 | MAP3K7 | 0.30055679 |
| 137 | STK38L | 0.29886611 |
| 138 | PRKCA | 0.29703431 |
| 139 | MAP3K13 | 0.26476007 |
| 140 | CSNK1A1 | 0.26318936 |
| 141 | ALK | 0.26210158 |
| 142 | VRK1 | 0.26168284 |
| 143 | CSNK1G1 | 0.25793516 |
| 144 | GSK3A | 0.24907513 |
| 145 | SGK494 | 0.24078104 |
| 146 | SGK223 | 0.24078104 |
| 147 | PRKCZ | 0.21780965 |
| 148 | PTK6 | 0.20626648 |
| 149 | STK24 | 0.19769186 |
| 150 | GRK1 | 0.18065496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 6.22795457 |
| 2 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 5.50604447 |
| 3 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.21515872 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 5.19456177 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 4.98499894 |
| 6 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 4.87232318 |
| 7 | Sulfur metabolism_Homo sapiens_hsa00920 | 4.38370712 |
| 8 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 3.22962223 |
| 9 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.18213964 |
| 10 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.73038022 |
| 11 | Glutathione metabolism_Homo sapiens_hsa00480 | 2.67737208 |
| 12 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.52258211 |
| 13 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.52078572 |
| 14 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.44602878 |
| 15 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.22934558 |
| 16 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.22332366 |
| 17 | Sulfur relay system_Homo sapiens_hsa04122 | 2.14556127 |
| 18 | Retinol metabolism_Homo sapiens_hsa00830 | 2.12594830 |
| 19 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.05379231 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.83497627 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.74816869 |
| 22 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.68478094 |
| 23 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.43387467 |
| 24 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.43043318 |
| 25 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.42809566 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.39850424 |
| 27 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.34855088 |
| 28 | Circadian rhythm_Homo sapiens_hsa04710 | 1.21108072 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14479009 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.14186085 |
| 31 | Galactose metabolism_Homo sapiens_hsa00052 | 1.13813367 |
| 32 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.09965077 |
| 33 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.07011748 |
| 34 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03836441 |
| 35 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.01594825 |
| 36 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.99361771 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.95155828 |
| 38 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.92641321 |
| 39 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.84613615 |
| 40 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.82466518 |
| 41 | Mineral absorption_Homo sapiens_hsa04978 | 0.82250920 |
| 42 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79655484 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79088125 |
| 44 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.76030264 |
| 45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75389602 |
| 46 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.75024554 |
| 47 | Pertussis_Homo sapiens_hsa05133 | 0.74549973 |
| 48 | Bladder cancer_Homo sapiens_hsa05219 | 0.71220354 |
| 49 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71164813 |
| 50 | Histidine metabolism_Homo sapiens_hsa00340 | 0.71073178 |
| 51 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.69481701 |
| 52 | Peroxisome_Homo sapiens_hsa04146 | 0.69206496 |
| 53 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68130890 |
| 54 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66210183 |
| 55 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.63485379 |
| 56 | Bile secretion_Homo sapiens_hsa04976 | 0.62928232 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62790235 |
| 58 | Carbon metabolism_Homo sapiens_hsa01200 | 0.61941444 |
| 59 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.61476830 |
| 60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.61213410 |
| 61 | Proteasome_Homo sapiens_hsa03050 | 0.60891976 |
| 62 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.60381400 |
| 63 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.60112046 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56673509 |
| 65 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.55670573 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.53870914 |
| 67 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53641894 |
| 68 | Hepatitis C_Homo sapiens_hsa05160 | 0.53279440 |
| 69 | Cocaine addiction_Homo sapiens_hsa05030 | 0.52294066 |
| 70 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.48489168 |
| 71 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47733460 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47495130 |
| 73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46694767 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46490834 |
| 75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46304121 |
| 76 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.45564945 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.45530624 |
| 78 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.43932122 |
| 79 | Metabolic pathways_Homo sapiens_hsa01100 | 0.43472997 |
| 80 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.43305234 |
| 81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.43271003 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42380783 |
| 83 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42081964 |
| 84 | ABC transporters_Homo sapiens_hsa02010 | 0.42075746 |
| 85 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.41063370 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.40018933 |
| 87 | Tight junction_Homo sapiens_hsa04530 | 0.38507693 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.38501408 |
| 89 | Salmonella infection_Homo sapiens_hsa05132 | 0.37754425 |
| 90 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.37040737 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.35996383 |
| 92 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.34812205 |
| 93 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.34740528 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34061938 |
| 95 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.33919149 |
| 96 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33435645 |
| 97 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.32517943 |
| 98 | Ribosome_Homo sapiens_hsa03010 | 0.31310127 |
| 99 | Adherens junction_Homo sapiens_hsa04520 | 0.30278430 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.30093290 |
| 101 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.29868895 |
| 102 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.29575051 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.28792558 |
| 104 | Legionellosis_Homo sapiens_hsa05134 | 0.28743396 |
| 105 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.27992855 |
| 106 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.27544111 |
| 107 | Leishmaniasis_Homo sapiens_hsa05140 | 0.25443823 |
| 108 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.25298519 |
| 109 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.25165180 |
| 110 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.24212474 |
| 111 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.23475913 |
| 112 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.22901737 |
| 113 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21769967 |
| 114 | Amoebiasis_Homo sapiens_hsa05146 | 0.21584061 |
| 115 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21491776 |
| 116 | Prostate cancer_Homo sapiens_hsa05215 | 0.20578614 |
| 117 | Lysosome_Homo sapiens_hsa04142 | 0.19145756 |
| 118 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.19080654 |
| 119 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.19032995 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16584765 |
| 121 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.16396854 |
| 122 | Influenza A_Homo sapiens_hsa05164 | 0.16205888 |
| 123 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.15993174 |
| 124 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.15946009 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.15254300 |
| 126 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.14723105 |
| 127 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.14705111 |
| 128 | Thyroid cancer_Homo sapiens_hsa05216 | 0.14647650 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.14247760 |
| 130 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.14200413 |
| 131 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.13858495 |
| 132 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.13658298 |
| 133 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.13140368 |
| 134 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.12867709 |
| 135 | Axon guidance_Homo sapiens_hsa04360 | 0.11486518 |
| 136 | Phototransduction_Homo sapiens_hsa04744 | 0.11458785 |
| 137 | HTLV-I infection_Homo sapiens_hsa05166 | 0.10292655 |
| 138 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.10226695 |
| 139 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.10200871 |
| 140 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.10069393 |
| 141 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09905379 |
| 142 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.09778633 |
| 143 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.09592615 |
| 144 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.09399703 |
| 145 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.07902440 |
| 146 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.06524854 |
| 147 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.06493853 |
| 148 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.06397374 |
| 149 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.06071009 |
| 150 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06018574 |
| 151 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.04930275 |
| 152 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.03726685 |

